[Update on lymphomas: 1997, a profitable year]

Bull Cancer. 1998 Jan;85(1):45-7.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antigens, CD20 / immunology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Lymphoma / classification*
  • Lymphoma / pathology
  • Lymphoma / therapy*
  • Lymphoma, Follicular / drug therapy
  • Neoplasm Staging
  • Prognosis

Substances

  • Antibodies, Monoclonal
  • Antigens, CD20